|
BioScreening - organic compounds for screening
Drug Discovery and BioScreening NewsAlzheimer’s Study Leads To Better Drug For Infections - Research into Alzheimer’s disease seems an unlikely approach to yield a better way to fight urinary tract infections (UTIs), but that’s what scientists at Washington University School of Medicine in St. Louis and elsewhere recently reported.
One element links the disparate areas of research: amyloids, which are fibrous, sticky protein aggregates. [...]
University of California, San Francisco, Researcher Receives ASBMB-Merck Award - Bethesda, MD, December 12, 2009 –(PR.com)– James A. Wells, professor and chairman of the department pharmaceutical chemistry at the University of California, San Francisco, and director of UCSF’s small molecule discovery center, has been named the winner of the 2010 American Society for Biochemistry and Molecular Biology-Merck Award for his [...]
Techne accelerates sample concentration - The Techne Sample Concentrator provides fast solvent or diluent evaporation without sample loss when used with one of the company’s Dri-Block heaters.
The height-adjustable head of the concentrator delivers a flow of inert gas that removes evaporated solvent from the surface of solutions in tubes or 96-well plates.
Traditional methods of reducing [...]
Potent Novel Tool For Combating Autoimmune Diseases And Leukemia - A study carried out by the scientists at the Scripps Research Institute illustrated a novel, highly practical strategy for identifying molecules that avert a particular form of immune cells from launching assaults on their host. These findings have added a potent new-fangled tool to the ongoing investigation for probable treatments [...]
Karwar scientist’s theory to ‘weed’ out CO2 - KARWAR: While representatives of 192 countries are engaged in climate change debates at Copenhagen, Dr Ullas Naik, a marine scientist at the department of marine biology, at Karnatak University’s PG Centre, here has suggested the unassuming sea weed as a possible cure to the planet’s ills.Calling for the scientific culture [...]
Hi-tech microscopes make androgen therapy ‘personal’ - HOUSTON — (December 9, 2009) — On rare occasions, an infant is born with outward appearance of a female but the XY chromosomes of a male. If the child has a normal Y chromosome — the chromosome responsible for testicular development — the condition is known as androgen insensitivity syndrome.
Experts estimate [...]
2009: The Year That Was For Pfizer - (RTTNews) - True to expectations, Jeffrey Kindler, the CEO of Pfizer Inc. (PFE | Quote | Chart | News | PowerRating), scripted a new playbook for the drug giant in 2009, accelerating the process of transformation by clinching the largest pharmaceutical [...]
Model for powerful flu fighters from existing drugs - Computer compatibility tests might help flu-fighting drugs find their groove.
A pandemic of the H1N1 swine flu virus has health officials worried that the virus could develop resistance to drugs such as Tamiflu used to treat infected people. A new computerized screening method could help find new or already existing drugs that [...]
Therasis Obtains $12 Million From Tilocor in Series A Round - GA_googleCreateDomIframe(’google_ads_div_Press336′ ,’Press336′);
GA_googleFillSlot(”Press160″);
GA_googleCreateDomIframe(’google_ads_div_Press160′ ,’Press160′);
NEW YORK, NY — 12/08/09 [...]
InformexUSA 2010 - InformexUSA has become the leading resource for buyers and sellers of high-value chemistry for a broad range of applications. Today’s pharmaceutical innovators, agrochemical product makers, electronic materials producers and other manufacturers that come to Informex find what they need for business success: mainly new ideas that make a difference, and qualified companies with production assets [...]
Forma Therapeutics raises $25.5M in Series B round - Forma Therapeutics has closed on a Series B financing that raised a total of $25.5 million. The round was led by new investor Lilly Ventures. Lilly was joined by existing investors Novartis Option Fund and Bio*One Capital of Singapore. Lexington-based Cubist Pharmaceutical, Inc. also joined as a new equity investor through a conversion of a [...]
Anti-cancer compound wins scientist Biota Award - Walter and Eliza Hall Institute scientist Dr Guillaume Lessene has won this year’s Biota Award for Medicinal Chemistry, awarded by the Royal Australian Chemical Institute.
Dr Lessene, who runs a laboratory in the institute’s Structural Biology Division, won the award for his role in the discovery of several compounds that interact with a protein that has [...]
Alzheimer’s Research Provides Potential Treatment for UTI - One element links the disparate areas of research: amyloids, which are fibrous, sticky protein aggregates. Some infectious bacteria use amyloids to attach to host cells and to build biofilms, which are bacterial communities bound together in a film that helps resist antibiotics and immune attacks.
Amyloids also form in the nervous system in Alzheimer’s disease, Parkinson’s [...]
iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer - iThemba Pharmaceuticals’ service division and Pyxis Discovery announced today that they have signed a collaborative agreement to jointly market both companies’ services.
Pyxis’s world class computational chemistry and lead discovery expertise will be coupled with iThemba’s service division to provide medicinal and synthetic chemistry support to projects identified through Pyxis’ international client network. iThemba Pharmaceuticals and [...]
Drug giant will allow screening of its library of compounds to seek potential treatments for neglected diseases - The Drugs for Neglected Diseases initiative (DNDi) has announced an agreement with drug giant Pfizer that will allow it access to the Pfizer library of novel chemical entities, in order to screen it for compounds that could be developed into new treatments for three of the most neglected infectious diseases of poverty: human African trypanosomiasis [...]
Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman - 20-year Industry Veteran Brings Extensive Experience in Drug Discovery and Development
CAMBRIDGE, Mass., Nov. 23 /PRNewswire/ — Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced the appointment of pharmaceutical industry veteran Errol B. De Souza as Ligon’s Executive Chairman of the Board.
“I’m very pleased to welcome [...]
University of Minnesota invention will help speed development of drug treatments for heart failure - Contacts: Patty Mattern, University News Service, (612) 624-2801, mattern@umn.edu
John Merritt, Office of the Vice President for Research, (612) 624-2609
Stacie Byars, Celladon, (206) 660-2588
MINNEAPOLIS / ST. PAUL (11/23/2009) —Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of [...]
JAX–West Helps Search for Compounds That Radically Extend Lifespan - In 2004, Avi Kremer, a 29-year old Harvard Business School student, was diagnosed with ALS. Avi’s doctors told him there was nothing that modern medicine could do for him. In response, he and fellow students founded Prize4Life, Inc. , a non-profit organization dedicated to accelerating research for treating and curing ALS by using the [...]
Rising to the Challenge in R&D - There has long been a consensus within the pharmaceutical industry that innovation and productivity is a critical focus. Nevertheless, the number of new molecular entities (NMEs) approved each year by FDA shows that industry has not been improving its output, despite progress in development and implementation of enabling technologies.
Over the past 20 years there has [...]
Caprotec bioanalytics Opens U.S. Subsidiary to Exploit Capture Compound Mass Spec - Berlin-based Caprotec bioanalytics opened a U.S. subsidiary in Burlington, MA. The U.S. business will be responsible for North American sales, marketing, and support for the company’s Capture Compound Mass Spectrometry (CCMS) technology and related products.
Christian Jurinke, Ph.D., Caprotec’s head of product commercialization and distribution, has been appointed president of the new U.S. subsidiary. The business [...]
Links
|
|
